Sign in
4

Changes in Ownership

Lipocine Inc. Filed Acc 0001493152-26-000361

Options or other derivatives

  • Chief Executive Officer acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Patel Mahesh V. Chief Executive Officer 2026-01-02 Grant or award · Stock Option (Right to Buy) +25,000 $8.00 $200,000 182,668 D: show line 1 in the form
Loading xslF345X05/ownership.xml…